Volume 45, Issue 12 e14010
REVIEW

Molecular insights on chemopreventive and anticancer potential of carvacrol: Implications from solid carcinomas

Afza Ahmad

Afza Ahmad

Department of Biosciences, Integral University, Lucknow, India

Contribution: Conceptualization, Writing - original draft, Writing - review & editing

Search for more papers by this author
Mohd. Saeed

Mohd. Saeed

Department of Biology, College of Sciences, University of Hail, Hail, Saudi Arabia

Contribution: Conceptualization

Search for more papers by this author
Irfan A. Ansari

Corresponding Author

Irfan A. Ansari

Department of Biosciences, Integral University, Lucknow, India

Correspondence

Irfan A. Ansari, Department of Biosciences, Integral University, Kursi Road, Lucknow, Uttar Pradesh-226026, India.

Email: [email protected]

Contribution: Conceptualization, Supervision, Writing - original draft, Writing - review & editing

Search for more papers by this author
First published: 18 November 2021
Citations: 17

Funding information

This work was supported by the Department of Science and Technology, Govt. of India (IF170529).

Abstract

Globally, cancer is one of the deadliest diseases, estimated to cause 9.9 million deaths in 2020. Conventional cancer treatments commonly involve mono-chemotherapy or a combination of radiotherapy and mono-chemotherapy. However, the negative side effects of these approaches have been extensively reported and have prompted the search for new therapeutic drugs. Over the past few years, numerous dietary agents, medicinal plants, and their phytochemicals gained considerable therapeutic importance because of their anticancer, antiviral, anti-inflammatory, and antioxidant activities. Recent years have shown that essential oils possess therapeutic effects against numerous cancers. They are primarily used due to their lesser side effects than standard chemotherapeutic drugs. Carvacrol (CRV) is a phenolic monoterpenoid found in essential oils of oregano, thyme, pepperwort, wild bergamot, and other plants. Numerous anticancer reports of CRV substantiated that the main mechanistic action of CRV involves reduction in the viability of cancer cells and induction of apoptosis via both intrinsic and extrinsic pathways. CRV also obstructs the migration and invasion of cells leading to the suppressed proliferation rate. Furthermore, CRV mediates augmented ROS generation resulting in DNA damage and also halts the progression of cell cycle. Treatment of CRV modulates the expression of apoptotic proteins (Bax, Bad) and molecular targets of various signaling pathways (PI3K/AKT/mTOR, MAPKs, and Notch) in multiple solid carcinomas. Hence, this review aimed to acquire and disseminate the knowledge of chemopreventive and anticancer effects of CRV and the mechanisms of action already described for the compound against numerous cancers, including solid carcinomas, to guide future research.

Practical applications

Development and formulation of phytocompound based anticancer drug agents to counteract the aftereffects of chemotherapeutic drugs is a propitious approach. CRV is a monoterpenoid consisting of a phenolic group obtained from the essential oils of oregano and thyme. These plants are being used as food flavoring spice and as fragrance ingredient in various cosmetic formulations. For the use of CRV as an efficient chemopreventive agent, different therapeutic interactions of CRV along with its targeted pathways and molecules, involved in the regulation of onset and progression of various types of solid carcinomas, need to be studied and explored thoroughly.

CONFLICT OF INTEREST

The authors of the present communication declare no competing conflict of interest.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.